Rimasys GmbH

Rimasys GmbH is a company specializing in advanced medical education and training solutions, providing innovative anatomical models that enhance surgical planning and training for healthcare professionals. Founded in 2016 in Cologne, Germany, Rimasys GmbH focuses on creating lifelike anatomical specimens for medical education. The company is co-founded by André Passon, Marc Ebinger, and Robert Holz, with Marc Ebinger currently serving as CEO. In September 2022, AO Foundation acquired full-stake ownership in Rimasys, although financial terms remain undisclosed.

Rimasys specializes in advanced medical education and training solutions, primarily focusing on the development of lifelike anatomical specimens, including fractured and injured models that retain undamaged soft tissue. This innovative approach enhances the ability of medical professionals to navigate complex anatomical structures, improving surgical planning and training outcomes. The company also offers 3D printed bones, which are critical tools in transforming surgical practices and enhancing hands-on medical training. Their primary customer base includes healthcare institutions, surgical training facilities, and individual surgeons across various geographical markets, notably in Europe, North America, and Asia.

Rimasys delivers its offerings through programs such as the World Surgery Tour, which encompasses surgical events, hands-on courses, and educational videos. Rimasys generates revenue through business-to-business (B2B) transactions and service offerings. Their revenue model is structured around partnerships with medical institutions and organizations that facilitate surgical training. Clients typically engage in multi-tiered contracts that include access to specialized training courses, hands-on workshops, and educational content via subscriptions.

The company also provides tailored services through its Film Studio and Training Center, contributing to additional revenue streams. While specific pricing details are not disclosed, the structure accommodates varying levels of service based on client needs, enabling Rimasys to serve a broad range of healthcare professionals. Rimasys plans to enhance its product line with new offerings, focusing on advanced surgical training tools aimed at further improving medical education. The company is targeting expansion into new markets, particularly in Asia and North America, by 2024.

The acquisition by AO Foundation in September 2022 will support these initiatives, enabling Rimasys to scale operations and invest in developing innovative training solutions.